Published in Clin Immunol on June 01, 2001
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol (2005) 5.88
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest (2004) 3.44
Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med (2004) 2.84
Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc (2006) 2.61
Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med (2009) 2.53
Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest (2010) 1.90
N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition. Am J Physiol Lung Cell Mol Physiol (2009) 1.83
An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. Kidney Int (2004) 1.76
Transglutaminase 2 and its role in pulmonary fibrosis. Am J Respir Crit Care Med (2011) 1.68
Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J Exp Med (2007) 1.67
Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic Biol Med (2009) 1.61
Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol (2003) 1.47
A new direction in the pathogenesis of idiopathic pulmonary fibrosis? Respir Res (2001) 1.47
PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis. PLoS One (2011) 1.43
The Role of PPARs in Lung Fibrosis. PPAR Res (2007) 1.37
Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc (2006) 1.31
Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts. Am J Respir Cell Mol Biol (2009) 1.30
TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation. J Cell Mol Med (2009) 1.29
Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr Drug Targets (2013) 1.27
Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol (2009) 1.27
Latent herpesvirus infection augments experimental pulmonary fibrosis. Am J Respir Crit Care Med (2009) 1.25
Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions. J Med Genet (2005) 1.18
Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. J Immunol (2010) 1.17
Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal (2008) 1.15
Adenosine signaling and the regulation of chronic lung disease. Pharmacol Ther (2009) 1.14
Enhanced airway inflammation and remodeling in adenosine deaminase-deficient mice lacking the A2B adenosine receptor. J Immunol (2009) 1.14
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome. Curr Med Chem (2008) 1.13
Viruses as co-factors for the initiation or exacerbation of lung fibrosis. Fibrogenesis Tissue Repair (2008) 1.13
Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis. Sci Transl Med (2014) 1.10
Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury. PLoS One (2011) 1.06
The possible potential therapeutic targets for drug induced gingival overgrowth. Mediators Inflamm (2013) 1.06
Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis. Am J Respir Cell Mol Biol (2012) 1.06
The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease. FASEB J (2012) 1.01
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. Oncologist (2013) 0.99
Viral infection and aging as cofactors for the development of pulmonary fibrosis. Expert Rev Respir Med (2010) 0.99
Peroxisome proliferator-activated receptor-gamma ligands induce heme oxygenase-1 in lung fibroblasts by a PPARgamma-independent, glutathione-dependent mechanism. Am J Physiol Lung Cell Mol Physiol (2009) 0.96
Use of biomarkers of collagen types I and III fibrosis metabolism to detect cardiovascular and renal disease in chimpanzees (Pan troglodytes). Comp Med (2010) 0.96
Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF. Autophagy (2014) 0.95
The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiation. Am J Pathol (2011) 0.94
Targeting CD40L: a promising therapeutic approach. Clin Diagn Lab Immunol (2004) 0.92
A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol (2008) 0.91
Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis. Am J Respir Cell Mol Biol (2012) 0.89
Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases. FASEB J (2013) 0.88
Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease. Int J Rheumatol (2011) 0.87
Enhanced expression of interleukin-18 in serum and pancreas of patients with chronic pancreatitis. World J Gastroenterol (2006) 0.86
SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. J Interferon Cytokine Res (2006) 0.85
The role of the receptor for advanced glycation end-products in a murine model of silicosis. PLoS One (2010) 0.85
Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway. BMC Complement Altern Med (2012) 0.83
Characteristic pattern of skeletal muscle remodelling in different mouse strains. Int J Exp Pathol (2010) 0.83
Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2. Eur J Pharm Biopharm (2012) 0.83
MS80, a novel sulfated oligosaccharide, inhibits pulmonary fibrosis by targeting TGF-beta1 both in vitro and in vivo. Acta Pharmacol Sin (2009) 0.81
Hypertonic Saline (NaCl 7.5 %) Reduces LPS-Induced Acute Lung Injury in Rats. Inflammation (2015) 0.79
Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells. Respir Res (2005) 0.79
Lung interstitial cells during alveolarization. Korean J Pediatr (2010) 0.78
Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis. Clin Exp Immunol (2015) 0.78
Transforming growth factor beta 1 activation, storage, and signaling pathways in idiopathic pulmonary fibrosis in dogs. J Vet Intern Med (2014) 0.77
TNF-α mRNA expression correlates with TGF-β mRNA expression in vivo. Inflammation (2011) 0.77
Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis. Oxid Med Cell Longev (2015) 0.77
Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis. Fibrogenesis Tissue Repair (2016) 0.77
Bleomycin induces upregulation of lysyl oxidase in cultured human fetal lung fibroblasts. Acta Pharmacol Sin (2010) 0.77
CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells. J Immunol (2015) 0.76
Growth factor restriction impedes progression of wound healing following cataract surgery: identification of VEGF as a putative therapeutic target. Sci Rep (2016) 0.76
Profibrotic potential of prominin-1+ epithelial progenitor cells in pulmonary fibrosis. Respir Res (2011) 0.76
Bone Marrow-Derived Cells in the Pathogenesis of Lung Fibrosis. Curr Respir Med Rev (1) 0.76
Fibrocytes in the Pathogenesis of Chronic Fibrotic Lung Disease. Curr Respir Med Rev (2013) 0.75
Radiotherapy-Induced Skin Reactions Induce Fibrosis Mediated by TGF-β1 Cytokine. Dose Response (2017) 0.75
Profibrotic up-regulation of glucose transporter 1 by TGF-β involves activation of MEK and mammalian target of rapamycin complex 2 pathways. FASEB J (2016) 0.75
Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases. PLoS Genet (2015) 0.75
Comparison of acute proton, photon, and low-dose priming effects on genes associated with extracellular matrix and adhesion molecules in the lungs. Fibrogenesis Tissue Repair (2013) 0.75
Mechanisms of the alternative activation of macrophages and non-coding RNAs in the development of radiation-induced lung fibrosis. World J Biol Chem (2016) 0.75
Loss of miR-140 is a key risk factor for radiation-induced lung fibrosis through reprogramming fibroblasts and macrophages. Sci Rep (2016) 0.75
Small interfering RNAs (siRNAs) targeting TGF-beta1 mRNA suppress asbestos-induced expression of TGF-beta1 and CTGF in fibroblasts. J Environ Pathol Toxicol Oncol (2009) 0.75
Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s). Nanomedicine (2017) 0.75
High expression of CD40 on skin fibroblasts from patients with systemic sclerosis. Rheumatol Int (2007) 0.75
Atorvastatin has a protective effect in a mouse model of bronchial asthma through regulating tissue transglutaminase and triggering receptor expressed on myeloid cells-1 expression. Exp Ther Med (2017) 0.75
Etiological heterogeneity in sirenomelia. Pediatr Pathol (1986) 0.93
Lethal presentation of mosaic tetrasomy 12p (Pallister-Killian) syndrome. Ann Genet (1989) 0.82
Hormones and territorial behavior during breeding in snow buntings (Plectrophenax nivalis): an Arctic-breeding songbird. Horm Behav (1998) 0.81
A New Method for Estimating the Coverage of Mass Vaccination Campaigns Against Poliomyelitis From Surveillance Data. Am J Epidemiol (2015) 0.79
Proceedings: C1q production and secretion by fibroblasts. J Med Microbiol (1975) 0.75